Report Adverse Events
Glenmark Pharmaceuticals is committed to patient safety. Our Global Drug Safety Risk Management function monitors assess and reports on the safety of our medicines throughout the products’ lifecycles, from discovery and research to post-approval, when it becomes available to patients.
Glenmark Pharmaceuticals has established a systematic process for collecting, analyzing, and reporting safety information in order to optimize patient safety in compliance with local and global guidance regulations.
To report adverse events or quality complaints or to ask any questions about Glenmark products in Canada, please contact Innomar-Strategies:
Hours: 9:00 a.m. – 5:00 p.m., EST